UNH research seeks to quantify health outcomes based on food access, fiber intake and gut microbiota

The U.S. obesity epidemic continues to have profound impacts on individuals’ health and socioeconomic well-being

EMA’s CHMP recommends approval of BMS’ Opdivo

Opdivo and Yervoy combination is used for the first-line treatment of adult patients with colorectal cancer. Credit: Jo Panuwat D/Shutterstock. The European Medicines Agency’s (EMA)

November 18, 2024

Intelligent suit aims to improve rehabilitation after spinal cord injury

An intelligent suit is hoped to significantly improve rehabilitation after a serious spinal cord injury. The AI-supported solution will be developed over the next three

June 30, 2023

Oculis eye drop secures another late-stage win, this time in post-cataract surgery inflammation and pain

Oculis revealed another win for its eye drops in a Phase III trial in post-cataract surgery inflammation and pain — after touting an earlier late-stage

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.